𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Power and sample size for cost-effectiveness analysis: fFN neonatal screening

✍ Scribed by Kathleen A. Boyd; Andrew H. Briggs; Elisabeth Fenwick; John Norrie; Sarah Stock


Book ID
116351061
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
267 KB
Volume
32
Category
Article
ISSN
1551-7144

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


An opportunity cost approach to sample s
✍ A. Gafni; S. D. Walter; S. Birch; P. Sendi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

## Abstract The inclusion of economic evaluations as part of clinical trials has led to concerns about the adequacy of trial sample size to support such analysis. The analytical tool of cost‐effectiveness analysis is the incremental cost‐effectiveness ratio (ICER), which is compared with a threshol